PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences:
Live webcasts will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Ariane Lovell
Finn Partners
ariane.lovell@finnpartners.com
Real-Time Revenue Cycle Management and Clinical Workflow Optimization for Radiology Practices to Debut at RSNA…
SAN DIEGO, Nov. 25, 2024 /PRNewswire/ -- Cortechs.ai, a leading provider of AI-powered imaging solutions,…
ROSEMONT, Ill., Nov. 25, 2024 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) has…
Specialized for veterinary care, SmartRotate™ for Equine automatically presents each image in the correct orientation,…
New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy…
PLANO, Texas, Nov. 25, 2024 /PRNewswire/ -- Bimini Health Tech has received United States 510k…